title: SIADH associated with fluoxetine and sertraline therapy.
authors.forename: C
authors.initials: C
authors.lastname: Jackson
authors.forename: W
authors.initials: W
authors.lastname: Carson
authors.forename: J
authors.initials: J
authors.lastname: Markowitz
authors.forename: J
authors.initials: J
authors.lastname: Mintzer
mesh_terms: D015057:1-Naphthylamine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000367:Age Factors; D000368:Aged; D003866:Depressive Disorder / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline; D012964:Sodium / Q000097:blood
chemical_list: D015057:1-Naphthylamine; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline; D012964:Sodium